Surgical and procedural robotics
Robotic systems that assist surgeons with precision and minimally invasive procedures, now used across several specialties.
Some technologies are in routine use. Others are being piloted, and some are still early. We help you separate what is ready from what is worth watching. Our maturity labels reflect our assessment as of 16 November 2026.
Robotic systems that assist surgeons with precision and minimally invasive procedures, now used across several specialties.
Virtual visits and digital intake that extend access and reduce unnecessary travel for patients.
Connected devices that send readings to care teams, supporting chronic care and follow-up after discharge.
Genetic and molecular data that help guide diagnosis and treatment choice, especially in oncology and rare disease.
Patient-specific anatomical models for surgical planning, and custom prosthetics and orthotics.
Autonomous delivery and cleaning robots that reduce manual transport and support infection control.
Treatments that edit or replace genes to treat inherited disease. A gene-editing therapy for sickle cell disease has been approved in the UK and US, and more are in trials.
Read the gene therapy outlook →Drones that carry blood, vaccines, and lab samples between facilities, cutting transit time where roads are slow. Programs run in several countries; wider use depends on aviation rules.
Hospital networks hold many devices that are hard to patch. Device inventory, network segmentation, and zero-trust access reduce the chance that an attack reaches patient care.
Standard interfaces such as HL7 FHIR let systems share records securely. This is the base that most AI and analytics projects depend on.
Virtual models of beds, theaters, and staffing, used to test changes before making them on the ward.
Implanted and wearable devices that read neural signals, aimed at restoring movement or communication after paralysis. Clinical trials are under way; routine clinical use is some way off.
Fuel cells for on-site power, heat, and backup at critical facilities, and hydrogen for site fleets and forklifts. Promising for resilience, but cost and fuel supply vary widely by region.
Read the hydrogen overview →Early research into simulation and optimization for drug discovery and logistics. Not yet a practical clinical tool; we track it for planning.
Our confidence-tiered view of the next ten years, covering AI, care outside the hospital, data and security, genomics, robotics, and what to watch, is in our Outlook.
Read the 2036 outlookThe best predictor of success won’t be the technology. It will be integration, security, and clinical or operational buy-in.
Every technology we look at is judged on the same four questions.
Email info@zadapartners.com with the technology and the problem you want to solve.